| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/05/1998 | WO1998004682A1 Adipogenic differentiation of human mesenchymal stem cells |
| 02/05/1998 | WO1998004591A1 Novel parathyroid hormone-related peptide analogs |
| 02/05/1998 | WO1998004561A1 1-azoniabicyclo[2.2.1]heptane derivatives and pharmaceutical compositions containing them |
| 02/05/1998 | WO1998004559A2 Substituted triazolo-pyridazine derivatives as ligands for gaba receptors |
| 02/05/1998 | WO1998004556A1 Pyridazino [4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists |
| 02/05/1998 | WO1998004555A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| 02/05/1998 | WO1998004545A1 Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase |
| 02/05/1998 | WO1998004541A1 Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease |
| 02/05/1998 | WO1998004537A1 Novel compounds and compositions for treating diseases associated with tryptase activity |
| 02/05/1998 | WO1998004526A1 SUBSTITUTED SULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 02/05/1998 | WO1998004521A1 Potassium channel inhibitors |
| 02/05/1998 | WO1998004279A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin |
| 02/05/1998 | WO1998004277A1 Peptidyl prodrugs and methods of making and using the same |
| 02/05/1998 | WO1998004276A1 Use in a composition of an extract of at least one labiate |
| 02/05/1998 | WO1998004259A1 ANTITHROMBOTIC AND ANTIATHEROGENIC PHARMACEUTICAL COMPOSITION INCLUDING A THIENOPYRIDINE DERIVATIVE AND AN HMG-CoA-REDUCTASE INHIBITOR |
| 02/05/1998 | WO1998004257A1 Phosphatase inhibitors and methods of use thereof |
| 02/05/1998 | WO1998004248A1 Dietary supplements |
| 02/05/1998 | WO1998004135A1 Diphenyl heterocycles as potassium channel modulators |
| 02/05/1998 | WO1997049736A3 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 02/05/1998 | WO1997047744A3 T-cell selective interleukin-4 agonists |
| 02/05/1998 | WO1997040069A3 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | CA2262542A1 Novel compounds and compositions for treating diseases associated with tryptase activity |
| 02/05/1998 | CA2262013A1 Herpes simplex virus icp4 is an inhibitor of apoptosis |
| 02/05/1998 | CA2261974A1 Molecular model for vla-4 inhibitors |
| 02/05/1998 | CA2261886A1 Peptidyl prodrugs and methods of making and using the same |
| 02/05/1998 | CA2261814A1 Potassium channel inhibitors |
| 02/05/1998 | CA2261808A1 1-azoniabicyclo¬2.2.1|heptane derivatives and pharmaceutical compositions containing them |
| 02/05/1998 | CA2261793A1 Phosphatase inhibitors and methods of use thereof |
| 02/05/1998 | CA2261764A1 Dietary supplements |
| 02/05/1998 | CA2261581A1 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | CA2261563A1 Human proteolipid |
| 02/05/1998 | CA2261167A1 Substituted sulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity |
| 02/05/1998 | CA2258609A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| 02/04/1998 | EP0822255A2 CHO (Chinese Hamster Ovary) glycosylated antibodies and their use in therapy |
| 02/04/1998 | EP0822200A1 Synthesis of analogs of PTH and PTrP |
| 02/04/1998 | EP0822192A2 Inhibitors of beta-glucuronidase |
| 02/04/1998 | EP0822190A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/04/1998 | EP0822186A2 L-tert-leucine-2-pyridylamide |
| 02/04/1998 | EP0822185A1 B-3-adrenergic agonists as antidiabetic and antiobesity agents |
| 02/04/1998 | EP0822182A1 Substituted indanylidineacetylguanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicaments or diagnostic agents and medicaments containing them |
| 02/04/1998 | EP0822177A1 Process for producing rhein and diacerhein |
| 02/04/1998 | EP0821964A2 Use of adenosine and adenosine derivatives for analgesia and attenuation of stress or stress responses |
| 02/04/1998 | EP0821960A1 Use of xanthine derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821952A1 Use of isoxazole and crotonic acid amide derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821728A1 Tie-2 ligands, methods of making and uses thereof |
| 02/04/1998 | EP0821684A1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex |
| 02/04/1998 | EP0821683A1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex |
| 02/04/1998 | EP0821682A1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex |
| 02/04/1998 | EP0821681A1 Naphthalene derivatives, method of preparation and use |
| 02/04/1998 | EP0821674A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 02/04/1998 | EP0821671A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors |
| 02/04/1998 | EP0821670A1 N-aroylamino acid amides as endothelin inhibitors |
| 02/04/1998 | EP0821669A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors |
| 02/04/1998 | EP0821668A1 Derivatives of succinamide and their use as metalloproteinase inhibitor |
| 02/04/1998 | EP0821666A1 Derivatives of succinamide and their use as metalloproteinase inhibitors |
| 02/04/1998 | EP0821665A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase |
| 02/04/1998 | EP0821592A1 Compositions and methods for regulating hair growth |
| 02/04/1998 | EP0821591A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
| 02/04/1998 | EP0821590A1 Large area submucosal graft constructs and method for making the same |
| 02/04/1998 | EP0821589A1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 02/04/1998 | EP0821585A1 USE OF $g(a) 1L? AGONISTS IN THE TREATMENT OF INCONTINENCE |
| 02/04/1998 | EP0667856B1 Novel vitamin d analogues |
| 02/04/1998 | CN1172483A Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 02/04/1998 | CN1172434A Use of angiotensin II fragments and analogs thereof in tissue repair |
| 02/04/1998 | CN1172116A Aprotinin variants having improved properties |
| 02/04/1998 | CN1172104A Substituted lndanylidineacetylguanidines, process for their preparation, their use as medicaments of diagnostic and medicaments containing them |
| 02/04/1998 | CN1171958A Health-care oral liquor |
| 02/04/1998 | CN1037235C Use of 6-(substituted amino) purine cytokinin in preparation of antisenlity composition |
| 02/03/1998 | US5714606 Pyrrolidine-containing monomers and oligomers |
| 02/03/1998 | US5714508 Inhibitors of angiotensin ii |
| 02/03/1998 | US5714501 Antiallergenic/antiasthmatic agents |
| 02/03/1998 | US5714495 Anxiolytic agents, melatonin receptors for treating psychological disorders and analgesics, sleep disorders |
| 02/03/1998 | US5714484 α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 02/03/1998 | US5714381 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 02/03/1998 | US5714353 Safe vectors for gene therapy |
| 02/03/1998 | US5714155 Ethylenediamine derivative in a cosmetic or dermatological composition, and composition containing in particular a product having an irritant side effect |
| 02/03/1998 | US5714148 Chemical compounds |
| 02/03/1998 | US5714143 Use of manganese superoxide dismutase (MN-SOD) for preparing pharmaceutical compositions for low-dose treatment of diseases |
| 02/03/1998 | CA1339660C Derivatives of cyclohexane |
| 02/01/1998 | CA2184546A1 Method for treating pediatric high grade astrocytoma including brain stem glioma |
| 01/31/1998 | CA2211866A1 .beta.-adrenergic agonists |
| 01/29/1998 | WO1998003632A1 Bivalent agonists for g-protein coupled receptors |
| 01/29/1998 | WO1998003547A1 Antagonists of intestinotrophic glp-2 peptides |
| 01/29/1998 | WO1998003539A1 G-protein coupled receptor hnfds78 |
| 01/29/1998 | WO1998003516A1 Phosphinate based inhibitors of matrix metalloproteases |
| 01/29/1998 | WO1998003511A1 New triazolopurines, method of preparing them and their use as drugs |
| 01/29/1998 | WO1998003507A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 01/29/1998 | WO1998003502A1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 01/29/1998 | WO1998003494A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 01/29/1998 | WO1998003493A1 Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands |
| 01/29/1998 | WO1998003492A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/29/1998 | WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 01/29/1998 | WO1998003177A1 Method of treating sinusitis with uridine triphosphates and related compounds |
| 01/29/1998 | WO1998003174A1 Method for treating tumors having high ldl requirements employing mtp inhibitors |
| 01/29/1998 | WO1998003164A1 Thiol sulfone metalloprotease inhibitors |
| 01/29/1998 | WO1998003059A1 Galanin |
| 01/29/1998 | DE19629378A1 Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Triazolopurine new, processes for their preparation and their use as medicaments |
| 01/29/1998 | CA2262008A1 Bivalent agonists for g-protein coupled receptors |
| 01/29/1998 | CA2261162A1 Method for treating tumors having high ldl requirements employing mtp inhibitors |
| 01/29/1998 | CA2261031A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |